Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
Mustafa AlwaniAksam A YassinRaidh TalibAhmad R Al-QudimatOmar AboumarzoukRaed M Al-ZoubiFarid SaadKarim S HaiderAbdulla Al AnsariPublished in: Vascular health and risk management (2021)
In hypogonadal men with a history of CVD, TTh improves and preserves erectile function over prolonged periods with concurrent sustained improvements in cardiometabolic risk factors. Measuring ED and testosterone status may serve as an important male health indicator predicting subsequent CVD-related events and mortality and TTh may be an effective add-on treatment in secondary prevention of cardiovascular events in hypogonadal men with a history of CVD.
Keyphrases
- replacement therapy
- cardiovascular events
- cardiovascular disease
- risk factors
- coronary artery disease
- emergency department
- smoking cessation
- healthcare
- public health
- squamous cell carcinoma
- mental health
- type diabetes
- electronic health record
- risk assessment
- health information
- machine learning
- social media
- climate change
- artificial intelligence
- benign prostatic hyperplasia